Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quatro G Pesquisa & Desenvolvimento is a Brazilian biotechnology company focused on the development and commercialization of molecular biology reagents and diagnostic tools. Established as a spin-off from the Pontifical Catholic University of Rio Grande do Sul (PUCRS), the company is recognized for producing the first Brazilian recombinant Taq DNA polymerase. Their product line includes a wide range of enzymes, DNA ladders, and PCR master mixes designed for both research and clinical applications. By providing locally manufactured high-performance biotechnology products, Quatro G supports the scientific infrastructure and diagnostic capabilities within Brazil. The company maintains strong ties with academic institutions to drive innovation in protein engineering and molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quatro G Pesquisa & Desenvolvimento.